V642I APP-inducible neuronal cells: A model system for investigating Alzheimer's disorders

Biochemical and Biophysical Research Communications

Volumn 274, Issue 2, 2000, Pages 445-454

  Niikura, Takako ^a   Murayama, Norie ^a   Hashimoto, Yu Ichi ^a   Ito, Yuko ^a   Yamagishi, Yohichi ^a   Matsuoka, Masaaki ^a   Takeuchi, Yuji ^a   Aiso, Sadakazu ^a   Nishimoto, Ikuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Anti risk factor; Apoptosis; Caspase inhibitor; Disease mutation; Ecdysone inducible system; Electron microscopy; Neuronal death; Pertussis toxin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E2; DRUG VEHICLE; ECDYSONE; ESTRADIOL DERIVATIVE; ESTROGEN; PERTUSSIS TOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034596257     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3143     Document Type: Article

References (46)

1. 4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
2. Sandbrink R., Masters C. L., Beyreuther K. βA4-Amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J. Biol. Chem. 269:1994;1510-1517.
3. Neve R. L., Finch E. A., Dawes L. R. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron. 1:1988;669-677.
4. Hardy J. Framing β-amyloid. Nat. Genet. 1:1992;233-234.
5. Yamatsuji T., Okamoto T., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T. B., Nishimoto I. G-protein-mediated neuronal DNA fragmentation by familial Alzheimer's disease-associated V642 mutants of APP. Science. 272:1996;1349-1352.
6. Yamatsuji T., Okamoto T., Takeda S., Murayama Y., Tanaka N., Nishimoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J. 15:1996;498-509.
7. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacanà E., Sunderland T., Zhao B., Kusiak J. W., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
8. Zhao B., Chrest F. J., Horton W. E. Jr., Sisodia S. S., Kusiak J. W. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J. Neurosci. Res. 47:1997;253-263.
9. Luo J. J., Wallace W., Riccioni T., Ingram D. K., Roth G. S., Kusiak J. W. Death of PC12 cells and hippocampal neurons induced by adenoviral-mediated FAD human amyloid precursor protein gene expression. J. Neurosci. Res. 55:1999;629-642.
10. Giambarella U., Yamatsuji T., Okamoto T., Matsui T., Ikezu T., Murayama Y., Levine M. A., Katz A., Gautam N., Nishimoto I. G protein βγ complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. EMBO J. 16:1997;4897-4907.
11. No D., Yao T. P., Evans R. M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;3346-3351.
12. Ramirez R., Carracedo J., Zamzami N., Castedo M., Kroemer G. Pertussis toxin inhibits activation-induced cell death of human thymocytes, pre-B leukemia cells and monocytes. J. Exp. Med. 180:1994;1147-1152.
13. Carracedo J., Ramirez R., Marchetti P., Pintado O. C., Baixeras E., Martinez C., Kroemer G. Pertussis toxin-sensitive GTP-binding proteins regulate activation-induced apoptotic cell death of human natural killer cells. Eur. J. Immunol. 25:1995;3094-3099.
14. Yan G. M., Lin S. Z., Irwin R. P., Paul S. M. Activation of G proteins bidirectionally affects apoptosis of cultured cerebellar granule neurons. J. Neurochem. 65:1995;2425-2431.
15. Yin D. L., Ren X. H., Zheng Z. L., Pu L., Jiang L. Z., Ma L., Pei G. Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: Involvement of pertussis toxin-sensitive G proteins. Neurosci. Res. 29:1997;121-127.
16. Lin S. Z., Yan G. M., Koch K. E., Paul S. M., Irwin R. P. Mastoparan-induced apoptosis of cultured cerebellar granule neurons is initiated by calcium release from intracellular stores. Brain. Res. 771:1997;184-195.
17. Sharma K., Srikant C. B. G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification. Biochem. Biophys. Res. Commun. 242:1998;134-140.
18. Farkas I., Baranyi L., Liposits Z. S., Yamamoto T., Okada H. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience. 86:1998;903-911.
19. Okazawa M., Shiraki T., Ninomiya H., Kobayashi S., Masaki T. Endothelin-induced apoptosis of A375 human melanoma cells. J. Biol. Chem. 273:1998;12584-12592.
20. o. Nature. 362:1993;75-79.
21. Okamoto T., Takeda S., Murayama Y., Ogata E., Nishimoto I. Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J. Biol. Chem. 270:1995;4205-4208.
22. Okamoto T., Takeda S., Giambarella U., Matsuura Y., Katada T., Nishimoto I. Intrinsic G-coupling function of amyloid precursor protein as a novel target of V642 mutations linked to familial Alzheimer disease. EMBO J. 15:1996;3769-3777.
23. o heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 19:1999;1717-1727.
24. Kerr J. F. R., Harmon B. V. Definition and incidence of apoptosis: An historical perspective. Tomei L. D., Cope F. O. Apoptosis: The Molecular Basis of Cell Death. 1991;5-29 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Birge S. J., Mortel K. F. Estrogen and the treatment of Alzheimer's disease. Am. J. Med. 103:1997;36S-45S.
26. Higgins G. A., Large C. H., Rupniak H. T., Barnes J. C. Apolipoprotein E and Alzheimer's disease: a review of recent studies. Pharmacol. Biochem. Behav. 56:1997;675-685.
27. Inestrosa N. C., Marzolo M. P., Bonnefont A. B. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Mol. Neurobiol. 17:1998;73-86.
28. Jaffe A. B., Toran-Allerand C. D., Greengard P., Gandy S. E. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269:1994;13065-13068.
29. Xu H., Gouras G. K., Greenfield J. P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J. N., Seeger M., Relkin N. R., Liao F., Checler F., Buxbaum J. D., Chait B. T., Thinakaran G., Sisodia S. S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 4:1998;447-451.
30. Green P. S., Gridley K. E., Simpkins J. W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168.
31. Bonnefont A. B., Munoz F. J., Inestrosa N. C. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 441:1998;220-224.
32. Svensson A. L., Nordberg A. β-Estradiol attenuates amyloid β-peptide toxicity via nicotinic receptors. NeuroReport. 10:1999;3485-3489.
33. Mattson M. P., Robinson N., Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport. 8:1997;3817-3821.
34. Perillo B., Sasso A., Abbondanza C., Palumbo G. 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 20:2000;2890-2901.
35. Benjamin R., Leake A., McArthur F. K., Ince P. G., Candy J. M., Edwardson J. A., Morris C. M., Bjertness E. Protective effect of apoE ε2 in Alzheimer's disease. Lancet. 344:1994;473.
36. Smith A. D., Johnston C., Sim E., Nagy Z., Jobst K. A., Hindley N., King E. Protective effect of apo ε2 in Alzheimer's disease, Oxford Project to investigate memory and ageing. Lancet. 344:1994;473-474.
37. Ikeda K., Akiyama H., Arai T., Sahara N., Mori H., Usami M., Sakata M., Mizutani T., Wakabayashi K., Takahashi H. A subset of senile dementia with high incidence of the apolipoprotein E ε2 allele. Ann. Neurol. 41:1997;693-695.
38. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
39. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
40. Tolar M., Marques M. A., Harmony J. A. K., Crutcher K. A. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17:1997;5678-5686.
41. Moulder K. L., Narita M., Chang L. K., Bu G., Johnson E. M. Jr. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J. Neurochem. 72:1999;1069-1080.
42. Srivastava R. A., Bhasin N., Srivastava N. Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem. Mol. Biol. Int. 38:1996;91-101.
43. Bursztajn S., DeSouza R., McPhie D. L., Berman S. A., Shioi J., Robakis N. K., Neve R. L. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neurosci. 18:1998;9790-9799.
44. De Strooper B., Simons M., Multhaup G., Van Leuven F., Beyreuther K., Dotti C. G. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14:1995;4932-4938.
45. Nishimura I., Uetsuki T., Dani S. U., Ohsawa Y., Saito I., Okamura H., Uchiyama Y., Yoshikawa K. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J. Neurosci. 18:1998;2387-2398.
46. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N., Martin G. M., Mattson M. P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport. 8:1996;379-383.